Phase 2
Development Phase
1
Upcoming Catalysts
0
Historical Events
1
Regulatory Approvals
0 competitors in Subarachnoid Hemorrhage, Aneurysmal
View Full LandscapeTarget Indication
Subarachnoid Hemorrhage, Aneurysmal
Clinical Trial
NCT06359782Last updated: 10/10/2026
No patent data available. Pre-approval drugs may not have Orange Book listings.
Cinryze
Treatment and pre-procedure prevention of angioedema attacks in adults, adolescents and children (2 years old and above) with hereditary angioedema (HAE). Routine prevention of angioedema attacks in adults, adolescents and children (6 years old and above) with severe and recurrent attacks of hereditary angioedema (HAE), who are intolerant to or insufficiently protected by oral prevention treatments, or patients who are inadequately managed with repeated acute treatment.
View on EMA